학술논문
Idelalisib in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: First Results from the Nordic Lymphoma Group NLG-LBC-07 (ILIAD) Phase II Trial
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:33-33
Subject
Language
ISSN
0006-4971